News

The next round of applications for access to the TRANSVAC infrastructure services is now open with deadline 30 April 2012.

Two new members of staff took up their duties at EVI headquarters in Heidelberg on 10 January.

Friday, 7th January 2011: Professor Eilis McGovern, President of RCSI today signed an agreement signifying RCSI’s joining of the EVI.

Some 12 million Burkinabè aged between 1 and 29 years of age are currently receiving MenAfriVac

First call for applications is open. You can now apply for access to the TRANSVAC infrastructure services. Deadline 31 January 2011.

The new page listing vaccinology course has been created as a help to our partners and collaborators etc.

Dr. Chetan Chitnis, inventor of the EVI supported JAIVAC-1 malaria vaccine project, has received an Infosys award

The EC-funded, EVI coordinated project PHARVAT now has its own web site.

European stakeholders of vaccine research and development convened in Brussels yesterday. A private-public working group starts to prepare concrete proposals to strengthen Europe’s vaccine infrastructure.

The first vaccinations of the candidate malaria vaccine, JAIVAC-1, with Montanide ISA 720 VG as adjuvant, have been administered to the first group of volunteers in India.